Medical Treatment for Inoperable Malignant Bowel Obstruction: A Qualitative Systematic Review

Journal of Pain and Symptom Management

Volumn 33, Issue 2, 2007, Pages 217-223

  Mercadante, Sebastiano ^a   Casuccio, Alessandra ^a   Mangione, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

bowel obstruction; Cancer; corticosteroids; hyoscine butylbromide; octreotide

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; CHLORPROMAZINE; CORTICOSTEROID; DEXAMETHASONE; HALOPERIDOL; METHYLPREDNISOLONE; OCTREOTIDE; SCOPOLAMINE BUTYL BROMIDE; STOMACH SECRETION INHIBITOR;

ADVANCED CANCER; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; EVIDENCE BASED PRACTICE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HUMAN; INOPERABLE CANCER; INTESTINE OBSTRUCTION; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS; PARENTERAL NUTRITION; PATIENT COMPLIANCE; REVIEW; SKIN MANIFESTATION; SURVIVAL RATE; SYSTEMATIC REVIEW; XEROSTOMIA;

ADRENAL CORTEX HORMONES; BUTYLSCOPOLAMMONIUM BROMIDE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL OBSTRUCTION; MUSCARINIC ANTAGONISTS; NEOPLASMS; OCTREOTIDE;

EID: 33846813515     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.06.014     Document Type: Review

References (14)

1. Ripamonti C., and Mercadante S. Pathophysiology and management of malignant bowel obstruction. In: Doyle D., Hanks G.W., McDonald N., and Cherny N. (Eds). Oxford textbook of palliative medicine. 3rd ed. (2005), Oxford University Press, New York 496-506
2. Fainsinger R., Spachynski K., Hanson J., and Bruera E. Symptom control in terminally ill patients with malignant bowel obstruction (MBO). J Pain Symptom Manage 9 (1994) 12-18
3. Mercadante S. Assessment and management of mechanical bowel obstruction. In: Portenoy R.K., and Bruera E. (Eds). Topics in palliative care vol. 1 (1997), Oxford University Press, New York 113-130
4. Ripamonti C., Twycross R., Baines M., et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 9 (2001) 223-233
5. Feur D.J., and Broadley K.E. Systematic review and metanalysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncol 10 (1999) 1035-1041
6. Baines M., Oliver D.J., and Carter R.L. Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet ii (1985) 990-993
7. Mercadante S., Spoldi E., Caraceni A., Maddaloni S., and Simonetti M. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7 (1993) 295-299
8. Jadad A., Moore A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
9. Mercadante S., Ripamonti C., Casuccio A., Zecca E., and Groff L. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 8 (2000) 188-191
10. Ripamonti C., Mercadante S., Groff L., et al. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective, randomized trial. J Pain Symptom Manage 19 (2000) 23-34
11. Mystakidou K., Tsilika E., Kalaidopoulou O., et al. Comparison of octreotide administration vs. conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial. Anticancer Res 22 (2002) 1187-1192
12. Laval G., Girarder J., Lassauniere J., et al. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?. Palliat Med 14 (2000) 3-10
13. Hardy J., Ling J., Mansi J., et al. Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliat Med 12 (1998) 437-442
14. Mercadante S., Ferrera P., Villari P., and Marrazzo A. Aggressive pharmacological treatment for reversing bowel obstruction. J Pain Symptom Manage 28 (2004) 412-416